Mogroside III A2 05838 InChi: InChI=1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9

InChi: InChI=1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9

trade name Lynparza

InChiKey: XKFTZKGMDDZMJI-HSZRJFAPSA-N

Indometacin farnesil (IMF) is a newly synthesized prodrug of indomethacin designed to reduce the occurrence of side-effects by esterification of the carboxyl group of indomethacin with farnesol

Mogroside III A2 05838 InChi: InChI=1S/C20H16ClN3O2/c1-11-18-14-4-2-3-5-15(14)19(12-6-8-13(21)9-7-12)23-16(10-17(22)25)20(18)26-24-11/h2-9Mogroside III A2 is a cucurbitane glycoside. Mogroside III A2 can inhibit Epstein Barr virus early antigen (EBV EA) activation. Mogroside III A2 shows weak inhibitory effects on activation of NOR 1. Product information CAS Number: 88901 43 3 Molecular Weight: 963. 15 Formula: C48H82O19 Chemical Name: 2 {[2 hydroxy 6 (10 hydroxy 3a,6,6,9b,11a pentamethyl 7 {[3,4,5 trihydroxy 6 ({[3,4,5 trihydroxy 6 (hydroxymethyl)oxan 2 yl]oxy}methyl)oxan 2 yl]oxy}